• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国子宫癌肉瘤的趋势。

Trends of uterine carcinosarcoma in the United States.

机构信息

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA.

Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.

出版信息

J Gynecol Oncol. 2018 Mar;29(2):e22. doi: 10.3802/jgo.2018.29.e22. Epub 2018 Jan 5.

DOI:10.3802/jgo.2018.29.e22
PMID:29400015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5823983/
Abstract

OBJECTIVE

Uterine carcinosarcoma (UCS) is a rare type of high-grade endometrial cancer (EC) that has been understudied with population-based statistics due to its rarity. This study examined temporal trends in the proportion of UCS among women with EC.

METHODS

This is a retrospective observational study examining The Surveillance, Epidemiology, and End Results program between 1973-2013. Primary EC cases were eligible for analysis, and a time-specific proportion of UCS was examined during the study period.

RESULTS

UCS was seen in 11,000 (4.7%) women among 235,849 primary EC cases. Mean age at UCS diagnosis increased from 65.9 to 71.7 years between 1973-1989 and then decreased from 71.7 to 67.0 years between 1989-2013 (both, p<0.001). Proportion of Black women significantly increased during the study period (11.9%-20.0%, p<0.001), whereas the proportion of White women decreased from 86.0% to 60.5% between 1987-2013 (p<0.001). There was a significant increase in the proportion of UCS among primary EC from 1.7% to 5.6% between 1973-2013 (p<0.001). Among type II ECs (n=76,118), the proportion of UCS also increased significantly from 6.0% to 17.5% between 1973-2013 (p<0.001). An increasing proportion of UCS was seen in both young and older women but the magnitude of interval increase was larger in the older age group between 1973-2013 (<60 years, from 1.3% to 3.3%. p<0.001; and ≥60 years, from 2.6% to 7.0%, p<0.001).

CONCLUSION

Our study demonstrated that the proportion of UCS has significantly increased among EC, accounting for more than 5% in recent years.

摘要

目的

子宫癌肉瘤(UCS)是一种罕见的高级别子宫内膜癌(EC)类型,由于其罕见性,基于人群的统计学研究对其研究较少。本研究检查了 UCS 占 EC 女性比例的时间趋势。

方法

这是一项回顾性观察性研究,对 1973 年至 2013 年间的监测、流行病学和最终结果计划进行了检查。原发性 EC 病例符合分析条件,并在研究期间检查了 UCS 的时间特异性比例。

结果

在 235849 例原发性 EC 病例中,有 11000 例(4.7%)患有 UCS。UCS 诊断时的平均年龄从 1973-1989 年的 65.9 岁增加到 1989-2013 年的 71.7 岁(均,p<0.001)。在研究期间,黑人女性的比例显著增加(11.9%-20.0%,p<0.001),而白人女性的比例从 1987-2013 年的 86.0%下降到 60.5%(均,p<0.001)。1973-2013 年间,原发性 EC 中 UCS 的比例从 1.7%显著增加到 5.6%(p<0.001)。在 II 型 EC(n=76118)中,UCS 的比例也从 1973-2013 年的 6.0%显著增加到 17.5%(p<0.001)。1973-2013 年间,无论是年轻女性还是老年女性,UCS 的比例都在增加,但老年女性的间隔增长率更大(<60 岁,从 1.3%增加到 3.3%,p<0.001;≥60 岁,从 2.6%增加到 7.0%,p<0.001)。

结论

我们的研究表明,UCS 在 EC 中的比例显著增加,近年来超过 5%。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da05/5823983/e5611d53d37e/jgo-29-e22-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da05/5823983/97eaa57f46a4/jgo-29-e22-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da05/5823983/76a4910dc020/jgo-29-e22-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da05/5823983/92258fb4305b/jgo-29-e22-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da05/5823983/7eade6980668/jgo-29-e22-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da05/5823983/e5611d53d37e/jgo-29-e22-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da05/5823983/97eaa57f46a4/jgo-29-e22-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da05/5823983/76a4910dc020/jgo-29-e22-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da05/5823983/92258fb4305b/jgo-29-e22-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da05/5823983/7eade6980668/jgo-29-e22-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da05/5823983/e5611d53d37e/jgo-29-e22-g005.jpg

相似文献

1
Trends of uterine carcinosarcoma in the United States.美国子宫癌肉瘤的趋势。
J Gynecol Oncol. 2018 Mar;29(2):e22. doi: 10.3802/jgo.2018.29.e22. Epub 2018 Jan 5.
2
Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival.种族差异在子宫和卵巢癌肉瘤中的表现:基于人群的治疗和生存分析。
Gynecol Oncol. 2020 Apr;157(1):67-77. doi: 10.1016/j.ygyno.2020.01.017. Epub 2020 Feb 4.
3
Assessing endometrial cancer risk among US women: long-term trends using hysterectomy-adjusted analysis.评估美国女性子宫内膜癌风险:基于子宫切除术调整分析的长期趋势。
Am J Obstet Gynecol. 2019 Oct;221(4):318.e1-318.e9. doi: 10.1016/j.ajog.2019.05.024. Epub 2019 May 22.
4
Insulin-like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma.胰岛素样生长因子 2:与女性子宫癌肉瘤种族差异相关的预后不良生物标志物。
Cancer Med. 2018 Mar;7(3):616-625. doi: 10.1002/cam4.1335. Epub 2018 Feb 18.
5
Adjuvant radiation therapy in uterine carcinosarcoma: A population-based analysis of patient demographic and clinical characteristics, patterns of care and outcomes.子宫癌肉瘤的辅助放疗:基于人群的患者人口统计学和临床特征、治疗模式及结局分析
Gynecol Oncol. 2016 May;141(2):225-230. doi: 10.1016/j.ygyno.2016.02.013. Epub 2016 Feb 16.
6
Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999.1989 - 1999年2677例子宫肉瘤的监测、流行病学及最终结果分析
Gynecol Oncol. 2004 Apr;93(1):204-8. doi: 10.1016/j.ygyno.2003.12.029.
7
Racial disparities in high-risk uterine cancer histologic subtypes: A United States Cancer Statistics study.高危型子宫癌组织学亚型的种族差异:美国癌症统计研究。
Gynecol Oncol. 2021 May;161(2):470-476. doi: 10.1016/j.ygyno.2021.02.037. Epub 2021 Mar 13.
8
Uterine carcinosarcoma: Contemporary clinical summary, molecular updates, and future research opportunity.子宫癌肉瘤:当代临床总结、分子学新进展及未来研究机遇
Gynecol Oncol. 2021 Feb;160(2):586-601. doi: 10.1016/j.ygyno.2020.10.043. Epub 2020 Nov 9.
9
Incidence and survival rates of primary uterine carcinosarcoma in Korea: a National Cancer Registry study.韩国原发性子宫癌肉瘤的发病率和生存率:国家癌症登记研究。
J Gynecol Oncol. 2023 Jan;34(1):e9. doi: 10.3802/jgo.2023.34.e9. Epub 2022 Oct 12.
10
Uterine Sarcoma: Analysis of 13,089 Cases Based on Surveillance, Epidemiology, and End Results Database.子宫肉瘤:基于监测、流行病学和最终结果数据库的13089例病例分析
Int J Gynecol Cancer. 2016 Jul;26(6):1098-104. doi: 10.1097/IGC.0000000000000720.

引用本文的文献

1
Risk factors and treatment strategies for female reproductive system carcinosarcoma with metastasis.伴有转移的女性生殖系统癌肉瘤的危险因素及治疗策略
Transl Cancer Res. 2025 Aug 31;14(8):4748-4758. doi: 10.21037/tcr-2025-697. Epub 2025 Aug 25.
2
Carcinosarcoma of the Endometrium-Pathology, Molecular Landscape and Novel Therapeutic Approaches.子宫内膜癌肉瘤——病理学、分子格局与新型治疗方法
Medicina (Kaunas). 2025 Jun 26;61(7):1156. doi: 10.3390/medicina61071156.
3
Clinicopathological Predictors of Recurrence in Uterine Sarcomas-A Narrative Review.

本文引用的文献

1
Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention.肥胖与乳腺癌不良风险及预后:机制洞察与干预策略
CA Cancer J Clin. 2017 Sep;67(5):378-397. doi: 10.3322/caac.21405. Epub 2017 Aug 1.
2
Epithelial-mesenchymal transition in cancer metastasis through the lymphatic system.癌症通过淋巴系统转移过程中的上皮-间质转化
Mol Oncol. 2017 Jul;11(7):781-791. doi: 10.1002/1878-0261.12092. Epub 2017 Jun 26.
3
Integrated Molecular Characterization of Uterine Carcinosarcoma.子宫癌肉瘤的综合分子特征分析
子宫肉瘤复发的临床病理预测因素——一项叙述性综述
J Clin Med. 2025 Jul 9;14(14):4883. doi: 10.3390/jcm14144883.
4
Drug discovery in advanced and recurrent endometrial cancer: Recent advances.晚期和复发性子宫内膜癌的药物研发:最新进展
Oncol Res. 2025 Jun 26;33(7):1511-1530. doi: 10.32604/or.2025.061120. eCollection 2025.
5
Peritoneal cytology predicting distant metastasis in uterine carcinosarcoma: machine learning model development and validation.腹膜细胞学检查预测子宫癌肉瘤远处转移:机器学习模型的开发与验证
World J Surg Oncol. 2025 Apr 26;23(1):167. doi: 10.1186/s12957-025-03771-9.
6
Updates and controversies in the management of uterine serous carcinoma and uterine carcinosarcoma.子宫浆液性癌和子宫癌肉瘤治疗的进展与争议
Int J Gynecol Cancer. 2025 Mar;35(3):101672. doi: 10.1016/j.ijgc.2025.101672. Epub 2025 Jan 30.
7
Quality of life and survival in patients with uterine carcinosarcoma: A tertiary center observational study.子宫癌肉瘤患者的生活质量与生存情况:一项三级中心观察性研究。
Gynecol Oncol Rep. 2025 Jan 17;57:101679. doi: 10.1016/j.gore.2025.101679. eCollection 2025 Feb.
8
ARID1A in Gynecologic Precancers and Cancers.ARID1A 在妇科癌前病变和癌症中的作用。
Reprod Sci. 2024 Aug;31(8):2150-2162. doi: 10.1007/s43032-024-01585-w. Epub 2024 May 13.
9
HPV-negative and high-grade finding in Pap cytology.巴氏细胞学检查中HPV阴性及高级别发现
Cytojournal. 2024 Jan 4;21:2. doi: 10.25259/Cytojournal_57_2023. eCollection 2024.
10
Epidemiology, site-specific characteristics and survival of carcinosarcoma: a retrospective study based on SEER database.癌肉瘤的流行病学、部位特异性特征和生存:基于 SEER 数据库的回顾性研究。
BMJ Open. 2023 Dec 14;13(12):e077974. doi: 10.1136/bmjopen-2023-077974.
Cancer Cell. 2017 Mar 13;31(3):411-423. doi: 10.1016/j.ccell.2017.02.010.
4
Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble.35个工业化国家的未来预期寿命:基于贝叶斯模型集成的预测
Lancet. 2017 Apr 1;389(10076):1323-1335. doi: 10.1016/S0140-6736(16)32381-9. Epub 2017 Feb 22.
5
Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma.辅助治疗对Ⅰ期子宫癌肉瘤复发模式的影响。
Gynecol Oncol. 2017 Apr;145(1):78-87. doi: 10.1016/j.ygyno.2017.02.001. Epub 2017 Feb 16.
6
Epithelial-mesenchymal transition in tumor metastasis.肿瘤转移中的上皮-间质转化
Mol Oncol. 2017 Jan;11(1):28-39. doi: 10.1002/1878-0261.12017. Epub 2016 Dec 9.
7
Extent of pelvic lymphadenectomy and use of adjuvant vaginal brachytherapy for early-stage endometrial cancer.早期子宫内膜癌盆腔淋巴结清扫范围及辅助阴道近距离放疗的应用
Gynecol Oncol. 2017 Mar;144(3):515-523. doi: 10.1016/j.ygyno.2016.12.012. Epub 2016 Dec 23.
8
Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcoma.他莫昔芬相关子宫癌肉瘤女性患者的肿瘤特征及生存结局
Gynecol Oncol. 2017 Feb;144(2):329-335. doi: 10.1016/j.ygyno.2016.11.042. Epub 2016 Dec 5.
9
Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment.探讨肥胖在子宫内膜癌风险、预防及治疗中的作用。
J Clin Oncol. 2016 Dec 10;34(35):4225-4230. doi: 10.1200/JCO.2016.69.4638. Epub 2016 Nov 7.
10
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition.子宫和卵巢癌肉瘤的突变图谱表明组蛋白基因与上皮-间质转化有关。
Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12238-12243. doi: 10.1073/pnas.1614120113. Epub 2016 Oct 10.